YahooOctober 12, 2026 at 11:07 AM NY15 Days Ago
TEVA Gets FDA Nod for Weltruza as Once-Monthly LAI in Schizophrenia
Teva wins FDA approval for Weltruza, the first once-monthly subcutaneous olanzapine injection for adults with schizophrenia, with a U.S. launch expected soon.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
